가야대학교 분성도서관
주메뉴
자료검색
- Home
- 상세정보
상세정보
부가기능
Early Clinical Trial Design Recommendations in Oncology Based on Overall Success across Phases I, II, and III
상세 프로파일
| 자료유형 | E-Book |
|---|---|
| 개인저자 | Ruppert Stark, Amy S. |
| 단체저자명 | The Ohio State University. Biostatistics. |
| 서명/저자사항 | Early Clinical Trial Design Recommendations in Oncology Based on Overall Success across Phases I, II, and III. |
| 발행사항 | [S.l.] : The Ohio State University., 2017 |
| 발행사항 | Ann Arbor : ProQuest Dissertations & Theses, 2017 |
| 형태사항 | 204 p. |
| 소장본 주기 | School code: 0168. |
| ISBN | 9780438097766 |
| 일반주기 |
Source: Dissertation Abstracts International, Volume: 79-12(E), Section: B.
Adviser: Abigail Shoben. |
| 요약 | Conventionally, drug development has spanned three distinct phases, and the success rate for experimental drugs across phases has been less than 15% (Hay, Thomas, Craighead, Economides, and Rosenthal, 2014). Despite increased options for nonstan |
| 요약 | Phase I, II, and III trials were simulated for clinical scenarios defined by eight toxicity profiles and two nondecreasing efficacy profiles. Early results showed that correctly selecting the maximum tolerated dose (MTD) greatly impacted overall |
| 요약 | Based on our results, we make the following recommendations for design selection when data informing the shape of the dose-toxicity curve exist. If a large jump in toxicity between dose levels is expected, we recommend the standard 3+3 design, w |
| 일반주제명 | Biostatistics. |
| 언어 | 영어 |
| 기본자료 저록 | Dissertation Abstracts International79-12B(E). Dissertation Abstract International |
| 대출바로가기 | http://www.riss.kr/pdu/ddodLink.do?id=T15000279 |
소장정보
- 소장정보
인쇄
| No. | 등록번호 | 청구기호 | 소장처 | 도서상태 | 반납예정일 | 예약 | 서비스 | 매체정보 |
|---|---|---|---|---|---|---|---|---|
| 1 | WE00024979 | DP 574 | 가야대학교/전자책서버(컴퓨터서버)/ | 대출불가(별치) |
|
카피라이터
